Graypoint LLC’s Eli Lilly LLY Stock Holding History

Graypoint LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$7.11M	Buy	9,120 +32	+0.4%	+$24.9K	0.4%	48
2025 Q1	$7.51M	Buy	9,088 +388	+4%	+$323K	0.47%	41
2024 Q4	$6.72M	Buy	8,700 +381	+5%	+$315K	0.41%	46
2024 Q3	$7.37M	Buy	8,319 +386	+5%	+$347K	0.47%	42
2024 Q2	$7.18M	Buy	7,933 +271	+4%	+$217K	0.5%	41
2024 Q1	$5.96M	Buy	7,662 +258	+3%	+$184K	0.43%	50
2023 Q4	$4.32M	Buy	7,404 +916	+14%	+$535K	0.35%	64
2023 Q3	$3.49M	Buy	6,488 +723	+13%	+$373K	0.33%	73
2023 Q2	$2.7M	Buy	5,765 +834	+17%	+$350K	0.27%	74
2023 Q1	$1.69M	Buy	4,931 +1,278	+35%	+$431K	0.18%	94
2022 Q4	$1.34M	Buy	3,653 +261	+8%	+$92.5K	0.16%	104
2022 Q3	$1.1M	Buy	3,392 +667	+24%	+$211K	0.14%	112
2022 Q2	$883K	Buy	2,725 +443	+19%	+$133K	0.11%	130
2022 Q1	$654K	Buy	2,282 +123	+6%	+$31.7K	0.06%	173
2021 Q4	$596K	Buy	2,159 +281	+15%	+$71.2K	0.06%	174
2021 Q3	$434K	Sell	1,878 -61	-3%	-$15.1K	0.05%	179
2021 Q2	$445K	Buy	1,939 +385	+25%	+$77.3K	0.06%	170
2021 Q1	$290K	Buy	+1,554	New	+$304K	0.04%	194

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Graypoint LLC's LLY Position: Q2 2025 in Review

Graypoint LLC increased its Eli Lilly (LLY) stake by 0.35% in Q2 2025, buying an estimated $24.9K and bringing the position to 9,120 shares worth $7.11M. The position accounts for 0.4% of the portfolio, ranked #48.

Graypoint LLC first reported a position in LLY in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.51M in Q1 2025. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Graypoint LLC held 9,120 shares of Eli Lilly worth $7.11M as of Q2 2025.
Graypoint LLC bought 32 Eli Lilly shares in Q2 2025, an estimated $24.9K.
Eli Lilly made up 0.4% of Graypoint LLC's portfolio in Q2 2025, its #48 holding.
Graypoint LLC first reported a position in Eli Lilly in Q1 2021 and has held it in 18 quarters since.
Graypoint LLC's Eli Lilly position peaked at $7.51M in Q1 2025.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.